Literature DB >> 19197148

Alternative site of implantation affects tumor malignancy and metastatic potential in mice: its comparison to the flank model.

Lucia Speroni1, Victoria de Los Angeles Bustuoabad, Julieta Gasparri, Nadia Silvia Chiaramoni, María Cristina Taira, Raúl Alejandro Ruggiero, Silvia Del Valle Alonso.   

Abstract

MC-C fibrosarcoma and B16F0 melanoma tumors were implanted intradermally in the dorsal region of the foot of mice. Tumor progression was compared to standard implantation in the flank. Although foot tumors only reached 13% (MC-C) and 25% (B16F0) of the mean volume of flank tumors, a more malignant phenotype in terms of histology and survival rate was observed in this type of tumors. Moreover, lung metastases were only detected in hosts bearing foot tumors, in contrast to MC-C and B16F0 populations with tumors growing in the flank. In addition, cellular influx and local immune reaction were higher in the dorsal region of the foot. According to our results, the dermis of the flank allows excessive tumor growth due to its low reactivity. Thus, differences in innate and adaptive immune effectors between the evaluated tumor microenvironments would account for the differences in tumor malignancy. Due to its striking differences with the standard flank inoculation, the tumor implantation model herein introduced could be a valuable tool to study the metastatic potential of different cell lines and the microenvironment components affecting tumor growth.

Entities:  

Mesh:

Year:  2009        PMID: 19197148     DOI: 10.4161/cbt.8.4.7452

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  3 in total

1.  Identification of melanoma cells: a method based in mean variance of signatures via spectral densities.

Authors:  Esperanza Guerra-Rosas; Josué Álvarez-Borrego; Aracely Angulo-Molina
Journal:  Biomed Opt Express       Date:  2017-03-15       Impact factor: 3.732

Review 2.  Validation of Hepatocellular Carcinoma Experimental Models for TGF-β Promoting Tumor Progression.

Authors:  Serena Mancarella; Silke Krol; Alberto Crovace; Stefano Leporatti; Francesco Dituri; Martina Frusciante; Gianluigi Giannelli
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

3.  Tumor location impacts immune response in mouse models of colon cancer.

Authors:  Xianda Zhao; Lihua Li; Timothy K Starr; Subbaya Subramanian
Journal:  Oncotarget       Date:  2017-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.